메뉴 건너뛰기




Volumn 7, Issue 25, 2016, Pages 37966-37978

HDAC5, a potential therapeutic target and prognostic biomarker, promotes proliferation, invasion and migration in human breast cancer

Author keywords

Breast cancer; Drug target; HDAC inhibitor; Histone deacetylase; Proteasome inhibitor

Indexed keywords

BORTEZOMIB; HISTONE DEACETYLASE 5; HISTONE DEACETYLASE INHIBITOR; LMK 235; SHORT HAIRPIN RNA; UNCLASSIFIED DRUG; HDAC5 PROTEIN, HUMAN; HISTONE DEACETYLASE; TUMOR MARKER;

EID: 84978042578     PISSN: None     EISSN: 19492553     Source Type: Journal    
DOI: 10.18632/oncotarget.9274     Document Type: Article
Times cited : (56)

References (25)
  • 2
    • 84923206707 scopus 로고    scopus 로고
    • Rheumatoid arthritis: inflammation feeds inflammation-HDAC5 downregulation leads to activation of fibroblast-like synoviocytes in RA
    • Duarte JH. Rheumatoid arthritis: inflammation feeds inflammation-HDAC5 downregulation leads to activation of fibroblast-like synoviocytes in RA. Nat Rev Rheumatol. 2015; 11: 64.
    • (2015) Nat Rev Rheumatol , vol.11 , pp. 64
    • Duarte, J.H.1
  • 3
    • 84887959502 scopus 로고    scopus 로고
    • Injury-induced HDAC5 nuclear export is essential for axon regeneration
    • Cho Y, Sloutsky R, Naegle KM, Cavalli V. Injury-induced HDAC5 nuclear export is essential for axon regeneration. Cell. 2013; 155: 894-908.
    • (2013) Cell , vol.155 , pp. 894-908
    • Cho, Y.1    Sloutsky, R.2    Naegle, K.M.3    Cavalli, V.4
  • 4
    • 0034597816 scopus 로고    scopus 로고
    • Signaldependent nuclear export of a histone deacetylase regulates muscle differentiation
    • McKinsey TA, Zhang CL, Lu J, Olson EN. Signaldependent nuclear export of a histone deacetylase regulates muscle differentiation. Nature. 2000; 408: 106-111.
    • (2000) Nature , vol.408 , pp. 106-111
    • McKinsey, T.A.1    Zhang, C.L.2    Lu, J.3    Olson, E.N.4
  • 8
    • 4544322261 scopus 로고    scopus 로고
    • Reduced expression of class II histone deacetylase genes is associated with poor prognosis in lung cancer patients
    • Osada H, Tatematsu Y, Saito H, Yatabe Y, Mitsudomi T, Takahashi T. Reduced expression of class II histone deacetylase genes is associated with poor prognosis in lung cancer patients. Int J Cancer. 2004; 112: 26-32.
    • (2004) Int J Cancer , vol.112 , pp. 26-32
    • Osada, H.1    Tatematsu, Y.2    Saito, H.3    Yatabe, Y.4    Mitsudomi, T.5    Takahashi, T.6
  • 11
  • 12
  • 13
    • 84872823252 scopus 로고    scopus 로고
    • Histone Deacetylase (HDAC) inhibitors with a novel connecting unit linker region reveal a selectivity profile for HDAC4 and HDAC5 with improved activity against chemoresistant cancer cells
    • Marek L, Hamacher A, Hansen FK, Kuna K, Gohlke H, Kassack MU, Kurz T. Histone Deacetylase (HDAC) inhibitors with a novel connecting unit linker region reveal a selectivity profile for HDAC4 and HDAC5 with improved activity against chemoresistant cancer cells. J Med Chem. 2013; 56: 427-436.
    • (2013) J Med Chem , vol.56 , pp. 427-436
    • Marek, L.1    Hamacher, A.2    Hansen, F.K.3    Kuna, K.4    Gohlke, H.5    Kassack, M.U.6    Kurz, T.7
  • 15
    • 84896546844 scopus 로고    scopus 로고
    • mTORC1/C2 and pan-HDAC inhibitors synergistically impair breast cancer growth by convergent AKT and polysome inhibiting mechanisms
    • Wilson-Edell KA, Yevtushenko MA, Rothschild DE, Rogers AN, Benz CC. mTORC1/C2 and pan-HDAC inhibitors synergistically impair breast cancer growth by convergent AKT and polysome inhibiting mechanisms. Breast Cancer Res Treat. 2014; 144: 287-298.
    • (2014) Breast Cancer Res Treat , vol.144 , pp. 287-298
    • Wilson-Edell, K.A.1    Yevtushenko, M.A.2    Rothschild, D.E.3    Rogers, A.N.4    Benz, C.C.5
  • 16
    • 74549173443 scopus 로고    scopus 로고
    • Romidepsin and Belinostat synergize the antineoplastic effect of Bortezomib in mantle cell lymphoma
    • Paoluzzi L, Scotto L, Marchi E, Zain J, Seshan VE, O'Connor OA. Romidepsin and Belinostat synergize the antineoplastic effect of Bortezomib in mantle cell lymphoma. Clin Cancer Res. 2010; 16: 554-565.
    • (2010) Clin Cancer Res , vol.16 , pp. 554-565
    • Paoluzzi, L.1    Scotto, L.2    Marchi, E.3    Zain, J.4    Seshan, V.E.5    O'Connor, O.A.6
  • 17
    • 84877652831 scopus 로고    scopus 로고
    • Bortezomib and SAHA synergistically induce ROS-driven Caspase-dependent apoptosis of nasopharyngeal carcinoma and block replication of Epstein-Barr virus
    • Hui KF, Lam BH, Ho DN, Tsao SW, Chiang AK. Bortezomib and SAHA synergistically induce ROS-driven Caspase-dependent apoptosis of nasopharyngeal carcinoma and block replication of Epstein-Barr virus. Mol Cancer Ther. 2013; 12: 747-758.
    • (2013) Mol Cancer Ther , vol.12 , pp. 747-758
    • Hui, K.F.1    Lam, B.H.2    Ho, D.N.3    Tsao, S.W.4    Chiang, A.K.5
  • 19
    • 85001790682 scopus 로고    scopus 로고
    • CCR 20th Anniversary Commentary: expanding the epigenetic therapeutic portfolio
    • Bates SE, Robey RW, Piekarz RL. CCR 20th Anniversary Commentary: expanding the epigenetic therapeutic portfolio. Clin Cancer Res. 2015; 21: 2195-2197.
    • (2015) Clin Cancer Res , vol.21 , pp. 2195-2197
    • Bates, S.E.1    Robey, R.W.2    Piekarz, R.L.3
  • 21
    • 84927631211 scopus 로고    scopus 로고
    • BATF2 deficiency promotes progression in human colorectal cancer via activation of HGF/MET signaling: a potential rationale for combining MET inhibitors with IFNs
    • Liu Z, Wei P, Yang Y, Cui W, Cao B, Tan C, Yu B, Bi R, Xia K, Chen W, Wang Y, Zhang Y, Du X, Zhou X. BATF2 deficiency promotes progression in human colorectal cancer via activation of HGF/MET signaling: a potential rationale for combining MET inhibitors with IFNs. Clin Cancer Res. 2015; 21: 1752-1763.
    • (2015) Clin Cancer Res , vol.21 , pp. 1752-1763
    • Liu, Z.1    Wei, P.2    Yang, Y.3    Cui, W.4    Cao, B.5    Tan, C.6    Yu, B.7    Bi, R.8    Xia, K.9    Chen, W.10    Wang, Y.11    Zhang, Y.12    Du, X.13    Zhou, X.14
  • 24
    • 84944260579 scopus 로고    scopus 로고
    • Breast density and benign breast disease: risk assessment to identify women at high risk of breast cancer
    • Tice JA, Miglioretti DL, Li CS, Vachon CM, Gard CC, Kerlikowske K. Breast density and benign breast disease: risk assessment to identify women at high risk of breast cancer. J Clin Oncol. 2015; 33: 3137-3143.
    • (2015) J Clin Oncol , vol.33 , pp. 3137-3143
    • Tice, J.A.1    Miglioretti, D.L.2    Li, C.S.3    Vachon, C.M.4    Gard, C.C.5    Kerlikowske, K.6
  • 25
    • 33748794547 scopus 로고    scopus 로고
    • Theoretical basis, experimental design, and computerized simulation of synergism and antagonism in drug combination studies
    • Chou TC. Theoretical basis, experimental design, and computerized simulation of synergism and antagonism in drug combination studies. Pharmacol Rev. 2006; 58: 621-681.
    • (2006) Pharmacol Rev , vol.58 , pp. 621-681
    • Chou, T.C.1


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.